We recently discovered that LOX was involved in anaplastic thyroid cancer (ATC) progression and metastasis, and higher expression of LOX was associated with lower survival rates in patients with differentiated thyroid cancer [11]. The gene discussed is LOX; the disease is differentiated thyroid carcinoma.